Cardiovascular Events: Clinical Trials

3 trials for Cardiovascular Events, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 terminated. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Recruiting 2, Terminated 1

Follow Cardiovascular Events: new trials by email Literature Review of Cardiovascular Events trials Research Report on Cardiovascular Events

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy
Aspirin 80mg, Placebo Oral Tablet - Myocardial Infarction (MI), Cardiovascular Events
Phase 3RecruitingChinese University of Hong Kong25142026-02-102026-03-18
Colchicine in Chronic Kidney Disease Patients
colchicine treatment in chronic kidney disease patients, placebo treatment - Chronic Kidney Disease, Cardiovascular Events
Phase 3RecruitingHospital General Universitario Gregorio Marañon7442025-02-122025-05-31
A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People
Aliskiren, Amlodipine, Hydrochlorothiazide (HCTZ) - Cardiovascular Events
Phase 3TerminatedNovartis Pharmaceuticals23362011-01-012014-04-08

Narrower conditions

Myocardial Infarction (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Cardiovascular Diseases (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Heart Diseases (1)  ·  Infarction (1)  ·  Ischemia (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Myocardial Ischemia (1)  ·  Necrosis (1)  ·  Renal Insufficiency (1)

Interventions

Amlodipine (1)  ·  Aspirin (1)  ·  Hydrochlorothiazide (1)  ·  aliskiren (1)

Sponsors

Chinese University of Hong Kong (1)  ·  Hospital General Universitario Gregorio Marañon (1)  ·  Novartis Pharmaceuticals (1)

Countries

Spain (2)  ·  Argentina (1)  ·  Brazil (1)  ·  Canada (1)  ·  Chile (1)  ·  Colombia (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Hungary (1)  ·  India (1)  ·  Ireland (1)  ·  Israel (1)  ·  Malaysia (1)  ·  Netherlands (1)

Top investigators

James Yun Wong Lau, MD (1)

Results publications

PMID 11786451, PMID 20150346, PMID 21873632, PMID 22661458, PMID 24616335, PMID 24679062, PMID 25975531, PMID 28753697, PMID 34362780, PMID 34632437, PMID 35028736, PMID 38670139

NIH funding

2009 (1), 2023 (1)